TTM
$7.34
YoY change
+1684.2%
5Y CAGR
+133.6%
Peak year (2015)
$11.91
Latest annual
$6.78
EPS (Diluted) history chart for Gilead Sciences (GILD) from 1990 to 2025
Latest: $6.78
EPS (Diluted) growth chart for Gilead Sciences (GILD) from 1990 to 2025
Latest: +1684.2%
EPS (Diluted) history table for Gilead Sciences (GILD) from 1990 to 2025
| 2025 | $6.78 | +1684.2% | +$6.40 | ||
| 2024 | $0.38 | -91.6% | −$4.12 | ||
| 2023 | $4.50 | +23.6% | +$0.86 | ||
| 2022 | $3.64 | -26.2% | −$1.29 | ||
| 2021 | $4.93 | +4961.6% | +$4.83 | ||
| 2020 | $0.10 | -97.7% | −$4.12 | ||
| 2019 | $4.22 | +1.2% | +$0.05 | ||
| 2018 | $4.17 | +18.8% | +$0.66 | ||
| 2017 | $3.51 | -64.7% | −$6.43 | ||
| 2016 | $9.94 | -16.5% | −$1.97 | ||
| 2015 | $11.91 | +62.0% | +$4.56 | ||
| 2014 | $7.35 | +306.1% | +$5.54 | ||
| 2013 | $1.81 | +10.4% | +$0.17 | ||
| 2012 | $1.64 | -7.9% | −$0.14 | ||
| 2011 | $1.78 | +7.2% | +$0.12 | ||
| 2010 | $1.66 | +17.7% | +$0.25 | ||
| 2009 | $1.41 | +34.3% | +$0.36 | ||
| 2008 | $1.05 | +25.0% | +$0.21 | ||
| 2007 | $0.84 | -229.2% | +$1.49 | ||
| 2006 | −$0.65 | -251.2% | −$1.08 | ||
| 2005 | $0.43 | +72.0% | +$0.18 | ||
| 2004 | $0.25 | -658.0% | +$0.29 | ||
| 2003 | −$0.04 | -202.3% | −$0.09 | ||
| 2002 | $0.04 | +34.8% | +$0.01 | ||
| 2001 | $0.03 | -183.3% | +$0.07 | ||
| 2000 | −$0.04 | -19.6% | +$0.01 | ||
| 1999 | −$0.05 | +13.6% | −$0.01 | ||
| 1998 | −$0.04 | +58.7% | −$0.02 | ||
| 1997 | −$0.03 | +10.2% | −$0.00 | ||
| 1996 | −$0.02 | -39.3% | +$0.02 | ||
| 1995 | −$0.04 | -6.7% | +$0.00 | ||
| 1994 | −$0.04 | — | — | ||
| 1992 | −$0.03 | +120.0% | −$0.01 | ||
| 1991 | −$0.01 | -4.6% | +$0.00 | ||
| 1990 | −$0.01 | — | — |
- 2025$6.78+1684.2%
- 2024$0.38-91.6%
- 2023$4.50+23.6%
- 2022$3.64-26.2%
- 2021$4.93+4961.6%
- 2020$0.10-97.7%
- 2019$4.22+1.2%
- 2018$4.17+18.8%
- 2017$3.51-64.7%
- 2016$9.94-16.5%
- 2015$11.91+62.0%
- 2014$7.35+306.1%
- 2013$1.81+10.4%
- 2012$1.64-7.9%
- 2011$1.78+7.2%
- 2010$1.66+17.7%
- 2009$1.41+34.3%
- 2008$1.05+25.0%
- 2007$0.84-229.2%
- 2006−$0.65-251.2%
- 2005$0.43+72.0%
- 2004$0.25-658.0%
- 2003−$0.04-202.3%
- 2002$0.04+34.8%
- 2001$0.03-183.3%
- 2000−$0.04-19.6%
- 1999−$0.05+13.6%
- 1998−$0.04+58.7%
- 1997−$0.03+10.2%
- 1996−$0.02-39.3%
- 1995−$0.04-6.7%
- 1994−$0.04—
- 1992−$0.03+120.0%
- 1991−$0.01-4.6%
- 1990−$0.01—
EPS (Diluted) values are taken from Gilead Sciences's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About EPS (Diluted) at Gilead Sciences (GILD)
According to Gilead Sciences's latest reported financial statements, the company's current diluted EPS (TTM) is $7.34. Diluted earnings per share (EPS) is net income divided by the diluted weighted-average shares outstanding over the period. It expresses profit on a per-share basis — the figure investors use to value an individual share — and accounts for potential dilution from options, RSUs, and convertible securities.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
2025's annual diluted EPS for Gilead Sciences (GILD) came in at $6.78 – surged 1684.2% year-over-year.
Over 2020–2025 (5 years), Gilead Sciences diluted EPS expanded at a +133.6% compound annual rate, with mixed annual results across the window.
Gilead Sciences diluted EPS plunged from $11.91 in 2015 to $6.78 in 2025, a 43.1% drawdown.
$11.91 stands as the all-time-high annual diluted EPS, posted in 2015, against a low of −$0.65 during 2006.
Gilead Sciences EPS (Diluted) by Year
Gilead Sciences EPS (Diluted) 2025: $6.78
Gilead Sciences diluted EPS in 2025 was $6.78, surged 1684.2% from 2024.
Gilead Sciences EPS (Diluted) 2024: $0.38
2024's diluted EPS for Gilead Sciences came in at $0.38, plunged 91.6% below 2023.
Gilead Sciences EPS (Diluted) 2023: $4.50
Gilead Sciences posted diluted EPS of $4.50 in 2023, grew 23.6% from 2022.
Gilead Sciences EPS (Diluted) 2022: $3.64
In 2022, Gilead Sciences reported diluted EPS of $3.64, declined 26.2% below 2021.
Gilead Sciences EPS (Diluted) 2021: $4.93
Gilead Sciences diluted EPS in 2021 was $4.93.
See more financial history for Gilead Sciences (GILD). Or calculate EPS yourself.
Sector peers by EPS (Diluted)
Healthcare peers of Gilead Sciences (GILD), ranked by their latest diluted EPS
| $22.95 | |
| $14.23 | |
| $13.23 | |
| $11.03 | |
| $7.28 | |
| $6.54 | |
| $3.59 | |
| $2.37 |
- $22.95
- $14.23
- $13.23
- $11.03
- $7.28
- $6.54
- $3.59
- $2.37
Frequently asked questions
Gilead Sciences (GILD) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation